The FDA has awarded a fast-track designation to Astellas’ peanut allergy vaccine candidate.

Bavarian Nordic is closer to the finish line in the U.S. with its smallpox vaccine Imvamune.

Many people don't get the vaccines recommended by public health experts--and it's taking a toll on the U.S. economy. In fact, unvaccinated adults…

About 20 million people and one-third of children in the U.S. received AstraZeneca’s FluMist last year to protect against the seasonal virus, health officials…

Despite a renewed push by health officials to promote HPV vaccination, a new poll finds that only a minority of parents believe laws requiring the vaccines “…

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

On Monday, the New Jersey pharma announced its rVSV-ZEBOV has won the FDA’s Breakthrough Therapy Designation and the EMA’s Priority Medicines status.

Pfizer’s blockbuster vaccine Prevenar 13 will soon get a boost in a host of international markets. The shot won WHO backing in a new, easier-to-store…

Regulatory